Mycenax Biotech Inc.


Please enter the company code as 4726 Go to Link

Monocloneantibody Development Platform

Mycenax’ Monocloneantibody Development Platform speeds up the development of the manufacturing process and analytical methods for your monoclonal antibody.

Technology Platform

  • Cell Culture Process Development
    • Limited media and feed finetuning by mini-bioreactor
    • Cell culture adaptation by 5L scale bioreactor
  • Purification Process Development
    • Consists of three column steps, one virus inactivation step, and one nanofiltration step
    • Limited development to remove the impurity to a safety level
  • Analytical Method Development
    • Test of in-house established analytical methods for suitability
    • If platform methods are not suitable, customized method development possible
  • Process development time can be shortened to 6 months